JP2010535015A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535015A5
JP2010535015A5 JP2010517242A JP2010517242A JP2010535015A5 JP 2010535015 A5 JP2010535015 A5 JP 2010535015A5 JP 2010517242 A JP2010517242 A JP 2010517242A JP 2010517242 A JP2010517242 A JP 2010517242A JP 2010535015 A5 JP2010535015 A5 JP 2010535015A5
Authority
JP
Japan
Prior art keywords
composition
seq
monoclonal antibody
produced
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010517242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535015A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2008/001353 external-priority patent/WO2009012588A1/en
Publication of JP2010535015A publication Critical patent/JP2010535015A/ja
Publication of JP2010535015A5 publication Critical patent/JP2010535015A5/ja
Pending legal-status Critical Current

Links

JP2010517242A 2007-07-23 2008-07-23 免疫原性のポリペプチドおよびモノクローナル抗体 Pending JP2010535015A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96172307P 2007-07-23 2007-07-23
PCT/CA2008/001353 WO2009012588A1 (en) 2007-07-23 2008-07-23 Immunogenic polypeptides and monoclonal antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013089148A Division JP6204053B2 (ja) 2007-07-23 2013-04-22 免疫原性のポリペプチドおよびモノクローナル抗体

Publications (2)

Publication Number Publication Date
JP2010535015A JP2010535015A (ja) 2010-11-18
JP2010535015A5 true JP2010535015A5 (https=) 2011-08-11

Family

ID=40280955

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010517242A Pending JP2010535015A (ja) 2007-07-23 2008-07-23 免疫原性のポリペプチドおよびモノクローナル抗体
JP2013089148A Expired - Fee Related JP6204053B2 (ja) 2007-07-23 2013-04-22 免疫原性のポリペプチドおよびモノクローナル抗体
JP2015196681A Pending JP2016005482A (ja) 2007-07-23 2015-10-02 免疫原性のポリペプチドおよびモノクローナル抗体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013089148A Expired - Fee Related JP6204053B2 (ja) 2007-07-23 2013-04-22 免疫原性のポリペプチドおよびモノクローナル抗体
JP2015196681A Pending JP2016005482A (ja) 2007-07-23 2015-10-02 免疫原性のポリペプチドおよびモノクローナル抗体

Country Status (12)

Country Link
US (1) US8337846B2 (https=)
EP (1) EP2183366B1 (https=)
JP (3) JP2010535015A (https=)
KR (1) KR101595234B1 (https=)
CN (1) CN101802198B (https=)
AU (1) AU2008280799B2 (https=)
BR (1) BRPI0814127A2 (https=)
CA (1) CA2694466A1 (https=)
ES (1) ES2397488T3 (https=)
IL (1) IL203429A0 (https=)
WO (1) WO2009012588A1 (https=)
ZA (1) ZA201001260B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
CN102802664B (zh) 2009-12-22 2017-04-05 赛诺菲巴斯德有限公司 免疫原性组合物
US9649372B2 (en) 2009-12-22 2017-05-16 Sanofi Pasteur Limited Immunogenic compositions and related methods
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
KR20140009281A (ko) 2010-12-03 2014-01-22 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 스트렙토코커스 뉴모니애에 대한 면역화를 위한 조성물
WO2012156391A1 (en) 2011-05-17 2012-11-22 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
US9279815B2 (en) 2012-02-01 2016-03-08 Oklahoma Medical Research Foundation Human Streptococcus pneumoniae antibodies and uses therefor
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
CN105754952B (zh) * 2016-02-16 2020-07-10 中国农业科学院兰州兽医研究所 抗羊痘病毒k3l蛋白c末端的单克隆抗体及其应用
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
GB201711635D0 (en) 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
ES3063128T3 (en) * 2018-03-20 2026-04-15 Sanofi Pasteur Ltd Methods for determining adjuvanted protein concentration and percent adsorption using intrinsic fluorescence and system implemented to perform the method
EP4291306A1 (en) * 2021-02-09 2023-12-20 University of Georgia Research Foundation, Inc. Human monoclonal antibodies against pneumococcal antigens

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
DE69233012T2 (de) * 1991-11-22 2003-11-06 Fattom, Ali Ibrahim Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
US6582708B1 (en) * 2000-06-28 2003-06-24 The Procter & Gamble Company Tooth whitening substance
ES2322306T3 (es) 1998-12-21 2009-06-18 Medimmune, Inc. Proteinas de streptpcpccus pneumoniae y fragmentos inmunogenicos para vacunas.
ES2400280T3 (es) * 1998-12-23 2013-04-08 Id Biomedical Corporation Of Quebec Antígenos de estreptococos
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
CN100379758C (zh) * 1999-03-26 2008-04-09 科特克斯(Om)有限公司 肺炎链球菌抗原
AU2001269833A1 (en) * 2000-06-14 2001-12-24 Cytovax Biotechnologies, Inc. Use of coiled-coil structural scaffold to generate structure-specific peptides
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
AU2001270381B2 (en) * 2000-06-20 2007-05-24 Id Biomedical Corporation Streptococcus antigens
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0130215D0 (en) 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine
EP1456231A2 (en) * 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigens
US6720918B2 (en) * 2002-09-17 2004-04-13 Space Systems/Loral, Inc. Antenna distortion estimation and compensation
EP2333114A1 (en) * 2003-04-15 2011-06-15 Intercell AG S. pneumoniae antigens
KR20060034698A (ko) * 2003-07-10 2006-04-24 와이어쓰 홀딩스 코포레이션 화농성 연쇄상구균 시스테인 프로테아제의 재조합 발현 및이의 면역원성 조성물
US8105612B2 (en) * 2005-05-13 2012-01-31 Novartis Vaccines And Diagnostics, Inc. Serum resistance factors of gram positive bacteria
JP5509176B2 (ja) * 2011-10-21 2014-06-04 株式会社日立製作所 計算機システムおよび計算機システムにおけるモジュール引き継ぎ方法

Similar Documents

Publication Publication Date Title
JP2010535015A5 (https=)
CN112010965A (zh) 一种针对新冠病毒SARS-CoV-2棘突蛋白RBD区的单克隆抗体及其应用
CN105073196B (zh) 呼吸道合胞病毒f蛋白表位
CN111606993B (zh) 抗呼吸道合胞病毒的全人广谱中和抗体4f1及其应用
CN104844712B (zh) 肺炎链球菌蛋白抗原及其制备方法和应用
Basset et al. Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein
JP2012515551A5 (https=)
JP2005511010A6 (ja) 呼吸器合胞体ウイルス（ｒｓｖ）ｇタンパク質のペプチドとワクチンにおけるその利用
JP2005511010A (ja) 呼吸器合胞体ウイルス（ｒｓｖ）ｇタンパク質のペプチドとワクチンにおけるその利用
CN110642927A (zh) 一种蛋白在制备预防化脓隐秘杆菌感染的药物中的应用
US20100143394A1 (en) Synthetic streptococcus pneumoniae vaccine
EP0567470B1 (en) Pseudomonas peptide composition and method for producing the same
CN103724413B (zh) 旋毛虫副肌球蛋白b细胞抗原表位8a1及其应用
CN108794584B (zh) 一种胸膜肺炎放线杆菌免疫保护性抗原蛋白apjl_1380及其应用
CN118406142B (zh) 抗a族链球菌m蛋白保守表位肽的单克隆抗体及其应用
CN102174091B (zh) 截短表达鸭瘟病毒重组囊膜gI蛋白及其制备方法与应用
KR20100139096A (ko) 조성물, 방법 및 키트
CN112522210A (zh) 一种分泌抗小反刍兽疫病毒单克隆抗体的杂交瘤细胞株及其单抗与应用
Vorobieva et al. Analysis of recombinant group B streptococcal protein ScaAB and evaluation of its immunogenicity
Meinke et al. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens
CN1367833B (zh) 肺炎链球菌的蛋白质和核酸分子
CN112574297A (zh) 抗神经氨酸酶的单克隆抗体及其应用
CN105542003B (zh) 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体
US8501197B2 (en) Compositions and methods for stimulating immune response against Moraxella catarrhalis
CA2328130A1 (en) Moraxella catarrhalis proteins